ID24173A - 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan - Google Patents

1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan

Info

Publication number
ID24173A
ID24173A IDW20000461A ID20000461A ID24173A ID 24173 A ID24173 A ID 24173A ID W20000461 A IDW20000461 A ID W20000461A ID 20000461 A ID20000461 A ID 20000461A ID 24173 A ID24173 A ID 24173A
Authority
ID
Indonesia
Prior art keywords
heksahidro
benzazosin
metano
medicines
making
Prior art date
Application number
IDW20000461A
Other languages
English (en)
Inventor
Matthias Grauert
Andrian Carter
W D Bechtel
Thomas Weiser
Rainer Palluk
Uwe Pschorn
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID24173A publication Critical patent/ID24173A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IDW20000461A 1997-09-12 1998-09-09 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan ID24173A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19740110A DE19740110A1 (de) 1997-09-12 1997-09-12 Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ID24173A true ID24173A (id) 2000-07-13

Family

ID=7842134

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000461A ID24173A (id) 1997-09-12 1998-09-09 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan

Country Status (38)

Country Link
US (1) US6455538B1 (id)
EP (1) EP1015433B1 (id)
JP (1) JP3827528B2 (id)
KR (1) KR100601008B1 (id)
CN (1) CN1166640C (id)
AR (1) AR017095A1 (id)
AT (1) ATE267811T1 (id)
AU (1) AU751036B2 (id)
BG (1) BG64418B1 (id)
BR (1) BR9812443A (id)
CA (1) CA2302347C (id)
CO (1) CO5011117A1 (id)
CZ (1) CZ296909B6 (id)
DE (2) DE19740110A1 (id)
DK (1) DK1015433T3 (id)
EE (1) EE04398B1 (id)
ES (1) ES2222612T3 (id)
HR (1) HRP980502B1 (id)
HU (1) HUP0004588A3 (id)
ID (1) ID24173A (id)
IL (1) IL134572A (id)
MY (1) MY120550A (id)
NO (1) NO315650B1 (id)
NZ (1) NZ503710A (id)
PE (1) PE122899A1 (id)
PL (1) PL198486B1 (id)
PT (1) PT1015433E (id)
RS (1) RS49888B (id)
RU (1) RU2218334C2 (id)
SA (1) SA98190765B1 (id)
SK (1) SK284670B6 (id)
TR (1) TR200000697T2 (id)
TW (1) TW505645B (id)
UA (1) UA61973C2 (id)
UY (2) UY25175A1 (id)
WO (1) WO1999014199A1 (id)
YU (1) YU12000A (id)
ZA (1) ZA988285B (id)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6683089B2 (en) 2002-02-02 2004-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
US6828311B2 (en) 2002-05-29 2004-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulation for the parenteral application of a sodium channel blocker
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
DE10226814A1 (de) * 2002-06-15 2004-01-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung ischämischer Zustände
US20030235576A1 (en) * 2002-06-15 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of ischaemic conditions
PT1963280E (pt) 2005-12-22 2016-02-02 Newron Pharm Spa Derivados de 2-feniletilamino como cálcio e/ou moduladores do canal de sódio
EP2155663B1 (en) 2007-06-15 2017-11-29 Newron Pharmaceuticals S.p.A. Substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9447029B2 (en) 2011-06-27 2016-09-20 Newron Pharmaceuticals S.P.A. Fluorinated arylalkylaminocarboxamide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
US4208523A (en) 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
US5607941A (en) * 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
DE4121821A1 (de) * 1991-07-02 1993-01-14 Boehringer Ingelheim Kg Neue benzomorphane und ihre verwendung als arzneimittel
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
RS49888B (sr) 2008-08-07
EE04398B1 (et) 2004-12-15
EP1015433B1 (de) 2004-05-26
PE122899A1 (es) 1999-12-06
PL339061A1 (en) 2000-12-04
YU12000A (sh) 2002-11-15
CA2302347A1 (en) 1999-03-25
CA2302347C (en) 2008-06-17
DK1015433T3 (da) 2004-09-27
NO20001288D0 (no) 2000-03-10
DE19740110A1 (de) 1999-03-18
EP1015433A1 (de) 2000-07-05
BR9812443A (pt) 2000-09-26
ATE267811T1 (de) 2004-06-15
HUP0004588A2 (hu) 2001-07-30
TW505645B (en) 2002-10-11
TR200000697T2 (tr) 2001-01-22
CN1166640C (zh) 2004-09-15
AU751036B2 (en) 2002-08-08
PL198486B1 (pl) 2008-06-30
AR017095A1 (es) 2001-08-22
SA98190765B1 (ar) 2006-06-10
UY25439A1 (es) 1999-11-17
CO5011117A1 (es) 2001-02-28
CZ2000894A3 (cs) 2000-09-13
WO1999014199A1 (de) 1999-03-25
NO20001288L (no) 2000-03-13
IL134572A (en) 2005-05-17
KR100601008B1 (ko) 2006-07-19
ZA988285B (en) 1999-03-12
BG64418B1 (bg) 2005-01-31
NZ503710A (en) 2002-04-26
RU2218334C2 (ru) 2003-12-10
JP3827528B2 (ja) 2006-09-27
HRP980502B1 (en) 2005-02-28
IL134572A0 (en) 2001-04-30
MY120550A (en) 2005-11-30
NO315650B1 (no) 2003-10-06
EE200000129A (et) 2001-02-15
BG104232A (en) 2000-10-31
CN1269790A (zh) 2000-10-11
UA61973C2 (en) 2003-12-15
SK3342000A3 (en) 2000-09-12
CZ296909B6 (cs) 2006-07-12
ES2222612T3 (es) 2005-02-01
HUP0004588A3 (en) 2002-10-28
KR20010023879A (ko) 2001-03-26
UY25175A1 (es) 2000-12-29
HRP980502A2 (en) 1999-06-30
SK284670B6 (sk) 2005-08-04
PT1015433E (pt) 2004-08-31
JP2001516747A (ja) 2001-10-02
US6455538B1 (en) 2002-09-24
DE59811477D1 (de) 2004-07-01
AU9624298A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
ID22821A (id) Turunan sulfonamida, proses pembuatannya dan penggunaannya sebagai obat
ID17307A (id) Komposisi oral dan proses pembuatannya.
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID26172A (id) Proses pembuatan surfaktan-surfaktan alkilbenzenasulfonat dan produk-produknya
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
ID16930A (id) Peralatan fotovoltaik dan proses untuk produksinya
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ID15947A (id) Senyawa fenol dan proses pembuatannya
ID22852A (id) Bahan-bahan biokontrol antifungi, proses untuk membuatnya dan memperlakukannya
ID28728A (id) Komposisi dan proses pengkrepan
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
ID24714A (id) Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
ID17810A (id) Turunan-turunan 2,4-tiazolidindion tersubstitusi baru, proses untuk pembuatannya dan komposisi farmasi yang mengandungnya
ID27275A (id) Intermediet dan proses untuk pembuatan olanzapin
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID24600A (id) Proses pembuatan poliol-poliol polieter dan poliol yang dibuat bersamaan
ID26902A (id) Proses dan radas untuk pembuatan melamina
ID18521A (id) Proses asetoksilasi olefin-olefin
ID22511A (id) Lampu fluoresen dan metoda pembuatannya
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID23304A (id) Turunan-turunan diaza-spiro [3,5] nonana, proses pembuatan dan penggunaannya
ID18954A (id) Kopolimer, proses terhidrogenasi daripadanya, dan proses untuk memproduksinya
ID26985A (id) Amina-amina polisiklik tiazolidin-2-ilidena, proses pembuatannya, dan penggunaannya a sebagai bahas farmasi
ID18860A (id) Katalis hidrocracking distilat dan proses pembuatannya
ID26660A (id) Proses pembuatan butana-1,4-diol, gamma-butirolakton dan tetrahidrofuran